for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Smiths Detection Partners With Attomarker To Develop Triple Antibody Testing Device For Covid-19

July 8 (Reuters) - Smiths Group PLC:

* SMITHS DETECTION ANNOUNCES PARTNERSHIP WITH ATTOMARKER IN THE DEVELOPMENT OF A TRIPLE ANTIBODY TESTING DEVICE FOR COVID-19

* SMITHS DETECTION - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) HAS ALREADY APPROVED ATTOMARKER’S TRIPLE ANTIBODY TEST FOR NHS USE IN UK Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up